Lantern Pharma, Inc. (LTRN)
3.13
+0.62
(+24.70%)
USD |
NASDAQ |
May 14, 16:00
3.20
+0.07
(+2.24%)
After-Hours: 20:00
Lantern Pharma Shareholders Equity (Quarterly) : 6.534M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| BioVie, Inc. | 15.61M |
| Vertex Pharmaceuticals, Inc. | 19.36B |
| Acurx Pharmaceuticals, Inc. | 7.013M |
| ACADIA Pharmaceuticals, Inc. | 1.248B |
| Alnylam Pharmaceuticals, Inc. | 1.075B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 11.04M |
| Total Liabilities (Quarterly) | 4.505M |
| Debt to Equity Ratio | 0.012 |
| Current Ratio | 2.400 |
| Net Debt Paydown Yield | 0.12% |